Advances in multimodality imaging and the application of new cardiac imaging technologies for radiation-induced heart disease

iRadiology Pub Date : 2024-04-05 DOI:10.1002/ird3.72
Zeliu Du, Chuanqiang Lan, Lin Shen, Zhifeng Tian, Hongfei Hu, Jie Mei, Ye Feng, Mengqian Zhai, Junchao Yu, Kan Liu, Jiansong Ji, Chenying Lu
{"title":"Advances in multimodality imaging and the application of new cardiac imaging technologies for radiation-induced heart disease","authors":"Zeliu Du,&nbsp;Chuanqiang Lan,&nbsp;Lin Shen,&nbsp;Zhifeng Tian,&nbsp;Hongfei Hu,&nbsp;Jie Mei,&nbsp;Ye Feng,&nbsp;Mengqian Zhai,&nbsp;Junchao Yu,&nbsp;Kan Liu,&nbsp;Jiansong Ji,&nbsp;Chenying Lu","doi":"10.1002/ird3.72","DOIUrl":null,"url":null,"abstract":"<p>Radiation-induced heart disease (RIHD) is a heterogeneous, delayed, and potentially fatal adverse reaction to radiation that can damage all structures of the heart, including the pericardium, myocardium, coronary arteries, valves, and conduction system, leading to a series of diseases. Acute and chronic disease processes play a role in the development of RIHD, the onset times of which range from months to decades. However, the clinical manifestations of RIHD are usually insidious, overlap with several other diseases, and lack specificity. Cardiovascular imaging is essential for early diagnosis, follow-up, and outcome assessment in patients with RIHD. This review first describes the pathogenesis and clinical manifestations of RIHD before providing an overview of the practical approaches and research advances in multimodal cardiovascular imaging in patients with RIHD, including echocardiography, cardiac magnetic resonance (CMR) and nuclear medicine, and cardiac computed tomography (CT). Then, the value of new cardiac imaging assessments for the early diagnosis of RIHD is described, particularly with relation to speckle-tracking echocardiography, extracellular volume fraction assessment as a quantitative CMR technique, CMR myocardial strain assessment, positron emission tomography-CT myocardial perfusion imaging, CT-ECV, and CT strain assessment, amongst others. In addition, the advantages and disadvantages of each screening technique are compared with the aim of better guiding the follow-up and diagnosis of subclinical RIHD and preventing cardiovascular events.</p>","PeriodicalId":73508,"journal":{"name":"iRadiology","volume":"2 3","pages":"285-304"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ird3.72","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iRadiology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ird3.72","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Radiation-induced heart disease (RIHD) is a heterogeneous, delayed, and potentially fatal adverse reaction to radiation that can damage all structures of the heart, including the pericardium, myocardium, coronary arteries, valves, and conduction system, leading to a series of diseases. Acute and chronic disease processes play a role in the development of RIHD, the onset times of which range from months to decades. However, the clinical manifestations of RIHD are usually insidious, overlap with several other diseases, and lack specificity. Cardiovascular imaging is essential for early diagnosis, follow-up, and outcome assessment in patients with RIHD. This review first describes the pathogenesis and clinical manifestations of RIHD before providing an overview of the practical approaches and research advances in multimodal cardiovascular imaging in patients with RIHD, including echocardiography, cardiac magnetic resonance (CMR) and nuclear medicine, and cardiac computed tomography (CT). Then, the value of new cardiac imaging assessments for the early diagnosis of RIHD is described, particularly with relation to speckle-tracking echocardiography, extracellular volume fraction assessment as a quantitative CMR technique, CMR myocardial strain assessment, positron emission tomography-CT myocardial perfusion imaging, CT-ECV, and CT strain assessment, amongst others. In addition, the advantages and disadvantages of each screening technique are compared with the aim of better guiding the follow-up and diagnosis of subclinical RIHD and preventing cardiovascular events.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多模态成像的进展以及新型心脏成像技术在辐射诱发心脏病方面的应用
辐射诱发心脏病(RIHD)是一种异质性、延迟性和潜在致命性的辐射不良反应,可损害心脏的所有结构,包括心包、心肌、冠状动脉、瓣膜和传导系统,导致一系列疾病。急性和慢性疾病过程在 RIHD 的发病过程中都会发挥作用,发病时间从数月到数十年不等。然而,RIHD 的临床表现通常比较隐匿,与其他几种疾病重叠,而且缺乏特异性。心血管成像对于 RIHD 患者的早期诊断、随访和疗效评估至关重要。本综述首先介绍了 RIHD 的发病机制和临床表现,然后概述了 RIHD 患者多模式心血管成像的实用方法和研究进展,包括超声心动图、心脏磁共振 (CMR) 和核医学以及心脏计算机断层扫描 (CT)。然后,介绍了新的心脏成像评估对早期诊断 RIHD 的价值,特别是斑点追踪超声心动图、作为定量 CMR 技术的细胞外容积分数评估、CMR 心肌应变评估、正电子发射断层扫描-CT 心肌灌注成像、CT-ECV 和 CT 应变评估等。此外,还比较了每种筛查技术的优缺点,目的是更好地指导亚临床 RIHD 的随访和诊断,预防心血管事件的发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Issue Information An unusual large mass of sclerosing angiomatoid nodular transformation Exploring the feasibility of integrating ultra-high field magnetic resonance imaging neuroimaging with multimodal artificial intelligence for clinical diagnostics Three-dimensional time of flight magnetic resonance angiography at 5.0T: Visualization of the superior cerebellar artery Ultra-high field magnetic resonance imaging in theranostics of mental disorders
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1